“Biohit” Gastrin-17 Advanced - Taiwan Registration b9bf7822c69be948b70cbc110b733c21
Access comprehensive regulatory information for “Biohit” Gastrin-17 Advanced in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number b9bf7822c69be948b70cbc110b733c21 and manufactured by BIOHIT OYJ. The authorized representative in Taiwan is YOULUM BIOTECHNOLOGY CO., LTD..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Device Details
Registration Details
b9bf7822c69be948b70cbc110b733c21
Ministry of Health Medical Device Import No. 031116
DHA05603111608
Product Details
This reagent uses enzyme-linked immunosorbent assay (ELISA) technology for the quantitative detection of G-17 (P-G-17) in human EDTA anticoagulant plasma or G-17 (S-G-17) in serum. The data of the test can be mainly used in two aspects: 1) when combined with other indicators (pepsinogen I, pepsinogen II) can assist in the diagnosis of gastric atrophic gastritis; 2) evaluate whether the gastric acid secretion is normal. This reagent is intended for in vitro diagnostic use and is not suitable for the diagnosis of gastrinomas.
A Clinical chemistry and clinical toxicology
A1325 Gastrin Test System
Imported from abroad
Dates and Status
May 22, 2018
May 22, 2028